招聘簡介：
發(fā)現(xiàn)/藥物化學(xué)和化學(xué)/分子生物學(xué)的博士后研究金
一些博士后獎學(xué)金可在OTT實驗室獲得（http://www.massgeneral.org/research/researchlab.aspx？）ID=1768）位于美國馬薩諸塞州波士頓哈佛醫(yī)學(xué)院馬薩諸塞總醫(yī)院癌癥研究中心。我們是一個由專門的科學(xué)家組成的團(tuán)隊，他們利用計算生物學(xué)、化學(xué)和功能遺傳學(xué)的學(xué)科來為癌癥定義新的基因調(diào)控目標(biāo)。具體來說，我們有興趣開發(fā)早期化學(xué)探針，以針對淋巴惡性腫瘤（急性白血病、淋巴瘤、骨髓瘤）中的必需染色質(zhì)調(diào)節(jié)劑。
英文原文：
Post-doctoral fellowships in discovery/medicinal chemistry and chemical/molecular biology
Several post-doctoral fellowships are available in the Ott Laboratory (http://www.massgeneral.org/research/researchlab.aspx?id=1768) at the Center for Cancer Research, Massachusetts General Hospital, Harvard Medical School – Boston, MA, United States. We are a team of dedicated scientists that use the disciplines of computational biology, chemistry, and functional genetics to define novel gene regulatory targets for cancer. Specifically, we are interested in developing early-stage chemical probes to target essential chromatin modulators in lymphoid malignancies (acute leukemia, lymphoma, myeloma).
Position 1: Discovery/medicinal chemistry of essential gene regulatory factors in cancer
The lab is recruiting a post-doctoral synthetic organic chemist with significant experience in small molecule chemistry, and a keen understanding of the principles of medicinal chemistry and translational pharmacology. The ideal candidate will also have a basic understanding of cellular and molecular biology. Available projects include synthesis of chemical probes targeting lysine acetylation pathways, transcription factor ligand development, and deployment of next-generation pharmacologic strategies including targeted protein degradation and covalent probe synthesis. Candidate(s) will have a Ph.D. in organic chemistry, medicinal chemistry, or related discipline.
Position 2: Chemical/molecular biology of essential gene regulatory factors in cancer
The lab is recruiting a post-doctoral molecular or chemical biologist with a significant interest in using functional and chemical genetics to probe the essential gene regulatory factors of lymphoid malignancies. The ideal candidate(s) will have a Ph.D., M.D., or M.D./Ph.D. in molecular biology, pharmacology, oncology, or related discipline. Familiarity with computational tools useful for genomics and epigenomics research is desirable. Available projects in the lab include understanding mechanisms of cancer cell dependency on lineage-defining gene regulatory factors and associated epigenetic machinery, high-throughput assay design and screening for novel chemical probes, functional genetic screening with gene editing technology to identify new therapeutic targets, and genome-wide chromatin structure analysis to understand gene regulatory malfunction in lymphoid malignancies.
Both positions require a high level of self-motivation, excellent communication skills, and the ability to work diligently and cooperatively with others. Successful applicants will be able to work independently, maintain high standards of laboratory safety, and display the intellectual curiosity required to effectively lead multidisciplinary projects.
Interested candidates should send a cover letter, CV, and the contact details of three references directly to:
Christopher Ott, PhD
christopher.ott@mgh.harvard.edu
為防止簡歷投遞丟失請抄送一份至：boshijob@126.com（郵件標(biāo)題格式：應(yīng)聘職位名稱+姓名+學(xué)歷+專業(yè)+中國博士人才網(wǎng)）
中國-博士人才網(wǎng)發(fā)布
聲明提示：凡本網(wǎng)注明“來源：XXX”的文/圖等稿件，本網(wǎng)轉(zhuǎn)載出于傳遞更多信息及方便產(chǎn)業(yè)探討之目的，并不意味著本站贊同其觀點或證實其內(nèi)容的真實性，文章內(nèi)容僅供參考。
